{"id":"https://openalex.org/W2289893079","doi":null,"title":"Systemic administration of interleukin-2 in humans.","display_name":"Systemic administration of interleukin-2 in humans.","publication_year":1984,"publication_date":"1984-10-01","ids":{"openalex":"https://openalex.org/W2289893079","mag":"2289893079","pmid":"https://pubmed.ncbi.nlm.nih.gov/6334135"},"language":"en","primary_location":{"id":"pmid:6334135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6334135","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biological response modifiers","raw_type":"Comparative Study"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024528047","display_name":"Michael T. Lotze","orcid":"https://orcid.org/0000-0003-3988-5419","observed_orcids":["https://orcid.org/0000-0003-3988-5419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M T Lotze","raw_affiliation_strings":["Surgery Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery Branch","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110019333","display_name":"Richard J. Robb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R J Robb","raw_affiliation_strings":["Glenolden Laboratories, E. I. duPont"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glenolden Laboratories, E. I. duPont","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059703792","display_name":"Susan O. Sharrow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S O Sharrow","raw_affiliation_strings":["National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L W Frana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L W Frana","raw_affiliation_strings":["Surgery Branch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgery Branch","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072133376","display_name":"Steven A. Rosenberg","orcid":"https://orcid.org/0000-0002-8939-8910","observed_orcids":["https://orcid.org/0000-0002-8939-8910"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S A Rosenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.5385,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.9402784,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"3","issue":"5","first_page":"475","last_page":"82"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3379000127315521,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3379000127315521,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.23770000040531158,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.1598999947309494,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/systemic-administration","display_name":"systemic administration","score":0.6940000057220459},{"id":"https://openalex.org/keywords/jurkat-cells","display_name":"Jurkat cells","score":0.7770000100135803},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.8769999742507935},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.718999981880188},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/hyperbilirubinemia","display_name":"hyperbilirubinemia","score":0.8309999704360962},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.6970000267028809},{"id":"https://openalex.org/keywords/aids","display_name":"AIDS","score":0.7360000014305115},{"id":"https://openalex.org/keywords/lymphokine-activated-killer-cells","display_name":"lymphokine-activated killer cells","score":0.8059999942779541},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9470000267028809},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.7699999809265137},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.5379999876022339},{"id":"https://openalex.org/keywords/immune-effects","display_name":"immunological effects","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7699505090713501},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.6419634819030762},{"id":"https://openalex.org/C2778594517","wikidata":"https://www.wikidata.org/wiki/Q2260058","display_name":"Chills","level":2,"score":0.631008505821228},{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.5814332962036133},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.5661609768867493},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5641418695449829},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.5078938603401184},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4936867654323578},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43858394026756287},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40171119570732117},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37447232007980347},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2523050904273987},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12503385543823242},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10096797347068787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007962","descriptor_name":"Leukocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008934","descriptor_name":"Mitogens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:6334135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6334135","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biological response modifiers","raw_type":"Comparative Study"},{"id":"mag:2289893079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6334135","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1600577617","https://openalex.org/W1563660543","https://openalex.org/W1643040145","https://openalex.org/W1965861552","https://openalex.org/W1977096306","https://openalex.org/W2045863333","https://openalex.org/W1592924232","https://openalex.org/W2416128450","https://openalex.org/W2260574412","https://openalex.org/W2286471357"],"abstract_inverted_index":{"Twelve":[0],"patients":[1,40,49,155],"were":[2,37,203,233],"treated":[3],"in":[4,31,39,48,82,153,190,215,227,229],"a":[5,70,93,99,206],"Phase":[6],"I":[7],"trial":[8],"of":[9,35,79,91,96,101,112,115,119,123,130,134,143,193,237],"purified":[10,159],"human":[11],"interleukin-2":[12],"(IL-2)":[13],"derived":[14],"from":[15],"the":[16,191,218,230],"JURKAT":[17,80],"cell":[18,196],"line":[19],"(E.I.":[20],"duPont":[21],"Corp.,":[22],"Glenolden,":[23],"PA,":[24],"U.S.A.).":[25],"The":[26,76],"serum":[27,77],"half-life,":[28],"toxicity,":[29],"and":[30,47,110,125,127,224],"vivo":[32],"immunologic":[33,175],"effects":[34,176],"IL-2":[36,62,81,92],"studied":[38],"with":[41,50,98],"cancer":[42],"unresponsive":[43],"to":[44,220],"standard":[45],"therapy":[46],"acquired":[51],"immunodeficiency":[52,168],"syndrome":[53],"(AIDS).":[54],"Patients":[55],"received":[56],"0.25,":[57],"2.5,":[58],"or":[59,65,137,140,166,179,188,210],"25":[60],"micrograms/kg":[61],"by":[63,200],"bolus":[64],"24-h":[66],"continuous":[67],"infusion":[68],"on":[69,164,205],"weekly":[71],"basis":[72,208],"for":[73],"4":[74],"weeks.":[75],"half-life":[78,100],"humans":[83],"was":[84,104,108,146,151,170],"approximately":[85],"6":[86],"min.":[87],"At":[88],"higher":[89],"doses":[90],"second":[94],"component":[95],"clearance":[97],"30-120":[102],"min":[103],"found.":[105],"Acute":[106,213],"toxicity":[107,139],"minimal":[109],"consisted":[111],"headache":[113],"(6":[114,122],"12),":[116,120,124],"nausea":[117],"(4":[118],"malaise":[121],"fever":[126],"chills":[128],"(8":[129],"12).":[131],"No":[132,161,172],"evidence":[133,142],"pulmonary,":[135],"hematologic,":[136],"renal":[138],"any":[141],"autoimmune":[144],"phenomena":[145],"detected.":[147],"A":[148],"transient":[149],"hyperbilirubinemia":[150],"seen":[152,204],"two":[154],"receiving":[156],"2":[157],"mg":[158,239],"IL-2.":[160,240],"demonstrable":[162],"effect":[163],"tumors":[165],"chronic":[167,174],"(AIDS)":[169],"seen.":[171],"consistent":[173],"(natural":[177],"killer":[178,181],"lymphokine-activated":[180,222],"activity,":[182],"mitogen":[183],"responsiveness,":[184,217],"total":[185],"lymphocyte":[186],"counts,":[187],"change":[189],"proportion":[192],"various":[194],"mononuclear":[195,231],"phenotypes":[197],"as":[198],"defined":[199],"monoclonal":[201],"antibody)":[202],"week-to-week":[207],"during":[209],"following":[211,235],"therapy.":[212],"changes":[214],"lymphokine":[216],"ability":[219],"generate":[221],"killers,":[223],"an":[225],"increase":[226],"macrophages":[228],"population":[232],"noted":[234],"administration":[236],"1-2":[238]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}